Cochrane Abstracts
Interleukin‐receptor antagonist and tumor necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Interleukin‐receptor Antagonist and Tumor Necrosis Factor Inhibitors for the Primary and Secondary Prevention of Atherosclerotic Cardiovascular Diseases." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435877/all/Framing_of_health_information_messages:_Cochrane_systematic_review. Accessed 23 April 2024.
Interleukin‐receptor antagonist and tumor necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435877/all/Framing_of_health_information_messages:_Cochrane_systematic_review. Accessed April 23, 2024.
Interleukin‐receptor antagonist and tumor necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435877/all/Framing_of_health_information_messages:_Cochrane_systematic_review
Interleukin‐receptor Antagonist and Tumor Necrosis Factor Inhibitors for the Primary and Secondary Prevention of Atherosclerotic Cardiovascular Diseases [Internet]. In: Cochrane Abstracts. [cited 2024 April 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435877/all/Framing_of_health_information_messages:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Interleukin‐receptor antagonist and tumor necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases
ID - 435877
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435877/all/Framing_of_health_information_messages:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
